-Lactoglobulin (BLG) was conjugated with the Nhydroxysuccinimide ester of the dextran-glycylglycine adduct (DG-ONSu) to reduce the immunogenicity of BLG, a major allergen of cow's milk, and some immunological properties of the conjugate (DG-BLG) were studied. The conjugate was prepared by modifying BLG with DG-ONSu and purified in a Sephadex G-100 column. The analytical data for DG-BLG indicated that 5.2 moles of DG-ONSu with a mean molecular weight of 9,300 were covalently attached to the amino groups of the BLG molecule. Conjugation with DG-ONSu greatly decreased the reactivity of BLG with anti-BLG antibodies and suppressed their production in vivo due to its shielding action for epitope(s) on the protein's molecular surface. It was also found that DG-BLG was resistant to proteolytic enzymes. These findings allow us to suggest that DG-ONSu could be advantageously used to suppress the hypersensitivity mediated by IgG antibodies in milk allergy.
Most food allergies are mainly recognized as ''type I allergy,'' and the immune reactions caused by IgE antibodies are known to induce an immediate-type allergy in patients. The delayed-type hypersensitivity in cow's milk allergy that is mediated by IgG antibodies, which is classified as ''type III allergy,'' is as a serious factor as the hypersensitivity mediated by IgE antibodies: it has been reported that types I and III allergy respectively account for about 30% and 50% of milk allergies, and that 82% of patients with milk allergies indicated a sensitivity to -lactoglobulin (BLG). [1] [2] [3] [4] [5] A major allergen in milk allergy is bovine BLG, which is a relatively small protein of 162 residues with an 18.4 kDa molecular weight. 6) BLG is removed, either by digesting it with proteolytic enzymes or heat-treating milk and dairy products to suppress the allergic response. However, solving the problem of milk allergy by these methods is difficult, because the taste quality and nutritional value of the milk might be ruined.
Reducing the immunogenicity of allergenic proteins by conjugating them with polymers or carbohydrates has therefore received considerable attention. For example, methoxypolyethylene glycol (mPEG) has proved successful in improving not only the physical and functional properties but also the immunogenicity of the conjugated proteins. [7] [8] [9] [10] However, mPEG is an artificial polymer and it is preferable to select natural and nonharmful products as modifying materials when preparing protein conjugates to minimize food allergens. The use of carbohydrates is therefore considered to be optimal for preparing protein conjugates. In addition, the reaction involved in modifying the allergens should be readily accomplished under mild conditions to prevent any deterioration of the proteins.
We synthesized in this study a dextran derivative (DG-ONSu), which is an N-hydroxysuccinimide ester of the dextran-glycylglycine adduct (DG), as a conjugating material to tailor proteins. We also prepared the BLG conjugate (DG-BLG) with DG-ONSu under mild conditions. Dextran is frequently used by the pharmaceutical, photographic, agricultural, cosmetic, and food industries because of its unique properties of being neutral, biocompatible, biodegradable, water soluble, and stable. Conjugating BLG, the main allergen in milk, with the dextran derivative was expected to achieve reduced immunogenicity. This paper describes the synthesis of DG-ONSu and some immunological properties of the resulting conjugate, DG-BLG, with regards to the hypersensitivity mediated by the IgG antibodies in milk allergy.
Materials and Methods
Materials. Skimmed milk was obtained from Snow Brand Milk Products Co., Ltd. (Sapporo, Japan). Dextran with a mean molecular weight of 9,300 was purchased from Sigma-Aldrich Co. (St. Louis, MO, USA). Dicyclohexylcarbodiimide (DCC) and N-hydroxysuccinimide (HONSu) were from Wako Pure Chemicals (Osaka, Japan).
Female BALB/c mice at 3 weeks of age were obtained from Kyudo Co. (Kumamoto, Japan). All other reagents used in this study were of high-quality analytical grade.
Purification of BLG. Bovine BLG was purified by the method described by Ebeler et al. and Erhardt with slight modifications. 11, 12) Skimmed milk (50 g) was stirred in 200 ml of a 0.5 M acetate buffer (pH 4.6) for 30 min. After removing the precipitate by centrifugation at 30 C (15,000 rpm for 30 min), trichloroacetic acid (12 g) was added to the supernatant. The mixture was stirred for 30 min and centrifuged at 4 C (15,000 rpm for 15 min). The collected supernatant was dialyzed against a 10 mM Na-borate buffer (pH 8.8) containing 0.1 M NaCl and then chromatographed in a Sephadex G-100 column (1:4 Â 69 cm) that had been equilibrated with the same buffer. The purity of each sample was confirmed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). 13) A sample (10 ml) of each fraction was taken and electrophoresed on 15% SDS-polyacrylamide gel. The fractions showing a single band were collected as BLG, dialyzed against deionized water, and finally lyophilized.
Synthesis of DG. The dextran-glycylglycine adduct, DG, was synthesized according to the previously described method with slight modifications. 14) Dextran (1.5 g) and glycylglycine (1.1 g) were dissolved in 7 ml of a 0.1 M phosphate buffer (pH 7.5) and reacted at 50 C for 2 h. After adding sodium cyanoborohydride (0.1 g), the mixture was stirred at 45 C for 4 d. The reaction mixture was then dialyzed against a 5 mM borate buffer (pH 9.0) and chromatographed in a DEAE-cellulofine A-200 column (2:4 Â 45 cm) that had been equilibrated with the same buffer. The column was developed with a linear gradient of 0-0.5 M NaCl, and 1.8-ml samples of the eluate were collected. Those fractions that were sugar-positive by the phenolsulfuric acid method 15) and showed UV-absorbance at 220 nm were pooled and lyophilized. The purified DG sample was then converted to its active ester.
Synthesis of DG-ONSu. DG-ONSu, an N-hydroxysuccinimide ester of DG, was synthesized by dissolving DG (300 mg) in 1 ml of dimethyl sulfoxide and reacting with DCC and HONSu at 35 C for 18 h. After removing the precipitate by centrifugation at 14,000 rpm for 10 min, cold acetone (30 ml) was added to the supernatant. The precipitate formed was collected by centrifugation at 4,000 rpm for 15 min, washed twice with cold acetone (30 ml), and dried in vacuo.
Preparation and purification of DG-BLG. BLG was conjugated with DG-ONSu according to the previously described method with slight modifications. 14) Briefly, DG-ONSu (300 mg) was added to a solution of BLG (10 mg in 7 ml of a 0.1 M Na-borate buffer (pH 8.0) over a period of 30 min while stirring, and the reaction proceeded at 4 C for 12 h. The mixture was then dialyzed against a 10 mM Naborate buffer (pH 8.8) containing 0.1 M NaCl at 4 C, before samples were chromatographed in a Sephadex G-100 column (1:4 Â 69 cm) that had been equilibrated with the same buffer. The column was developed with the equilibration buffer at 4 C. The eluate was monitored at 280 nm, and samples (0.1 ml) of each fraction were tested by the phenol-sulfuric acid method. 15) Those fractions containing BLG conjugated with the carbohydrate (DG-BLG) were collected, dialyzed against deionized water, and then lyophilized.
Protein concentrations. The concentration of BLG was measured spectrophotometrically by using an absorption coefficient of " ¼ 1:743 Â 10 4 M
À1 Ácm
À1 at 280 nm. The same value was used for DG-BLG, because it had a UV absorption spectrum identical to that of native BLG.
Counting free amino groups. The number of free amino groups in the modified proteins was determined by the trinitrobenzenesulfonate (TNBS) method as described by Fields.
16)
Preparation of mouse anti-BLG polyclonal antibodies. Anti-BLG polyclonal antibodies were prepared in mice by using native BLG as a soluble antigen. The antigen protein (5:4 Â 10 À9 mol) in Freund's complete adjuvant was intraperitoneally injected into BALB/c mice. Booster injections of the same amount of the antigen protein in Freund's incomplete adjuvant were administered twice at two-week intervals. All blood samples from the immunized mice were taken a week after the final injection, and the antiserum was prepared after centrifuging to remove any blood clots. The antiserum was stored at À20 C until used in the enzyme-linked immunosorbent assay (ELISA). Anti-DG-BLG polyclonal antibodies were also produced by using DG-BLG as a soluble antigen, and the antiserum was prepared by the same procedure as that just described.
Assay for immunogenicity by ELISA. The immunogenicity of BLG and its derivative were examined by the ELISA method. A 96-well microtiter plate was coated with BLG or modified BLG in a 0.1 M Na-carbonate buffer (pH 9.6) and incubated at 4 C overnight. The incubated plate was blocked with 1% bovine serum albumin in phosphate-buffered saline at pH 7.4 (PBS) and 37
C for 1 h. Samples (50 ml) of the supernatant of the anti-BLG antiserum obtained from the mice were added and incubated at 37
C for 1 h. The wells were washed three times with 0.05% Tween 20 in PBS and incubated at 37 C for 1 h with 100 ml/well of the horseradish peroxidaseconjugated goat antibody against mouse IgG. After washing the wells three times with PBS containing 0.05% Tween 20, 100 ml/well of the substrate solution (0.003% H 2 O 2 and 0.3 mg/ml of o-phenylenediamine in a 0.1 M citrate buffer at pH 4.0) was added, and the mixture was incubated at 37 C for 15 min. The enzyme reaction was stopped by adding 100 ml/well of a 1.5% oxalate solution, and the absorbance of the reaction mixture was read at 490 nm with an NJ-2201 Intermed Immunomini instrument.
Suppression assay of mouse anti-BLG antibody production. An immunological test for the suppression of anti-BLG antibody production after injecting DG-BLG was run by intraperitoneally injecting the antigen (DG-BLG, BLG, or PBS) into mice at given times according to the schedule shown in Table 1 . The mice in Group II were immunized with DG-BLG as the initial injection, while the mice in Group III were immunized with DG-BLG 14 d after the initial injection. All mice were injected with BLG 7 and 21 d after the initial injection. All blood samples from the immunized mice were taken a week after each injection. The amount of anti-BLG polyclonal antibodies was detected by the ELISA method already described.
Resistance assay to proteolytic enzymes. An assay of the resistance of BLG and its derivative to proteolytic enzymes was performed according to the method previously described. 17) BLG or its derivative was dissolved in a 50 mM borate buffer at pH 8.0 as a sample solution (1:8 Â 10 À6 M). The sample solution (50 ml) in a 96-well microtiter plate was reacted with trypsin or chymotrypsin dissolved in the same buffer (50 ml) at 37 C for a given time. The enzyme reaction was stopped by adding 50 ml/well of a 0.1 M sodium tetraborate solution containing 0.2 M sodium hydroxide and 5% SDS. The reaction mixture was then reacted with 50 mM TNBS (50 ml) for 10 min. After adding a 0.2 M sodium dihydrogenphosphate solution containing 5 mM sodium sulfite, the absorbance of the reaction mixture was read at 420 nm. Pepsin dissolved in 5% formic acid was used as a proteolytic enzyme in the resistance assay to pepsin, and the proteolytic reaction was performed at pH 2.0.
Results and Discussion
Preparation and purification of DG-BLG Bovine BLG is a major whey protein of cow's milk with a concentration of 3 g/l, 18) and we were able to obtain a sufficient amount of BLG from skimmed milk 19 ) the fractions showing a single band with a molecular mass of 18.4 kDa in the SDS-PAGE analysis were collected as purified BLG (data not shown). This gel filtration was effective for separating dimeric BLG from monomeric BLG and other proteins such as -casein and -lactoalbumin.
The synthetic route to DG-ONSu, the N-hydroxysuccinimide ester of DG, is shown in Fig. 1A . We developed in this study a new type of dextran derivative for preparing protein-carbohydrate conjugates under mild conditions by referring to the synthesis method for an active amylose derivative previously described. 14) Compared to such artificial materials as mPEG and cyanuric chloride, DG-ONSu, which is composed of only natural products, is thought to be a more suitable material for tailoring food proteins. The chemical structure of DG-ONSu is indicated in Fig. 1B . DGONSu was designed to form amide linkages with amino groups in the proteins and peptides. Since DG and DGONSu have sites for glycylglycine and carbohydrate chains, they could easily be detected in the purification process by monitoring the UV absorbance from peptide linkages at 220 nm and 490 nm by the phenol-sulfuric acid method. 15) In the purification of DG from the reaction mixture, using a DEAE-cellulofine A-200 column, DG was eluted with about 0.15 M NaCl and collected (data not shown). The obtained DG was then immediately converted to an N-hydroxysuccinimide ester by using the described method. A 133.5 mg amount of DG-ONSu was obtained in this way from 1.5 g of dextran. It should be possible to improve the low yield in the synthesis of DG-ONSu by further investigation, while a dextran derivative with high reactivity was obtained in this study. The purified BLG sample was then modified with DG-ONSu at 4 C in a neutral medium, and the reaction mixture was chromatographed in a Sephadex G-100 column to purify the resulting conjugate, DG-BLG. As shown in Fig. 2 , three major peaks (peaks 1-3) were obtained by monitoring the absorbance at 280 nm. The absorption at 490 nm enabled three peaks (peaks 4-6) with a sugar-positive nature to be detected. Thus, the fractions included in peak 2 that demonstrated both absorbance at 280 nm and 490 nm were found to contain DG-BLG.
On the other hand, peaks 1 and 3 were respectively considered to contain BLG cross-linked with residual DCC and monomeric BLG, since the fractions in both peaks only showed absorbance at 280 nm. The result that the fractions in peak 6 had a high sugar-positive nature and low sensitivity for absorption at 280 nm implies that the peak contained monomeric BLG conjugated with DG-ONSu. Since natural BLG in milk forms a stable dimeric structure, monomeric BLG conjugated with DG-ONSu in peak 6 is not an appropriate candidate for further immunological tests.
Judging from the elution position of BLG from gel filtration on Sephadex G-100, it is reasonable to suppose that the dimeric structure of BLG was maintained in DG-BLG incorporated in peaks 4 and 5. The difference in the apparent molecular weight of the DG-BLG fractions (peaks 4 and 5) was thought to indicate a different degree of modification of the BLG molecule n is assumed to be 57.3 in this study. Dex, GG, and DCC respectively denote dextran, glycylglycine, and dicyclohexylcarbodiimide.
with DG-ONSu. The results of immunogenicity tests lead us to believe that the enhanced masking effect of DG-ONSu on the protein surface led to decreased immunogenicity of the proteins. DG-BLG in peak 4 had a higher molecular weight considered to represent a modification that would have lower immunogenicity than that represented by peak 5. Therefore, the fractions shown by a horizontal bar, which seemed to contain a stable dimer of BLG that was highly conjugated with DG-ONSu, were pooled as DG-BLG for further immunological tests.
Number of modified amino groups
The number of free amino groups in DG-BLG was evaluated by the TNBS method to characterize the conjugate. 16) There are 16 amino groups in the BLG molecule (1 -amino group of the N-terminal leucine residue and 15 "-amino groups of lysine residues).
6) The TNBS method indicated that 10.8 moles of amino group/mole of DG-BLG were available for trinitrophenylation (data not shown). This implies that an average of 5.2 of the 16 amino groups in BLG were modified with DG-ONSu. Taking into account the molecular masses of BLG (18.4 kDa) and dextran (9.3 kDa), the resulting conjugate should show a sharp band of approximately 66.8 kDa in an SDS-PAGE analysis. However, since the protein mobility for SDS-PAGE is affected by differences in the molecular length of the carbohydrate chain in the case of glycoproteins, it is plausible that DG-BLG would produce a smear band as shown in Fig. 2 .
Nine amino groups (Leu1, Lys8, Lys14, Lys70, Lys75, Lys77, Lys100, Lys138, and Lys141) among the 16 amino groups in the BLG molecule had high solvent accessibility, and their side chains were highly exposed to the main chain of BLG, as suggested by the X-ray crystallographic data of Qin et al. 20) The N-terminal -amino group of Leu1 among these nine amino groups forms a salt bridge to Glu108, burying the latter side chain. In addition, in forming a stable dimeric structure in a solvent, Lys8 from one molecule acts as ''key'' inserted into the ''lock'' provided by a neighboring molecule. 20) Therefore, the seven other ''free and active'' amino groups of these side chains can be modified with DG-ONSu. To attain a better understanding of the conjugate, we have to identify the lysine residues to which DG-ONSu covalently binds. As we have previously reported that Lys 33 among the seven amino groups in the lysozyme molecule was predominantly modified by the mPEG derivative during the preparation of the lysozyme conjugate with mPEG, 8) further identification of the modified sites will lead to more efficient control of the immunogenicity of antigen proteins.
Lower reactivity of DG-BLG against mouse anti-BLG IgG antibodies
To examine the effect of modification with the dextran derivative on the antigen-recognition of antibodies, the reactivity of DG-BLG and BLG was measured by ELISA, using polyclonal antibodies produced from BALB/c mice. As shown in Fig. 3 , the reactivity of native BLG with anti-BLG IgG antibodies was markedly decreased by modification with DGONSu. The differences in the estimated IC 50 values from the immunogenicity curves between DG-BLG and native BLG were large, as summarized in Table 2 . Furthermore, the ELISA test with anti-DG-BLG IgG antibodies prepared by using DG-BLG as a soluble antigen showed that the reactivity of native BLG to the anti-DG-BLG IgG antibodies was nearly equal to that of DG-BLG (data not shown), and that the estimated IC 50 values were similar (Table 2) . These findings clearly indicate that the covalent attachment of the dextran derivative to BLG effectively decreased the immunogenicity of BLG.
The reduction of the binding affinity of DG-BLG for specific antibodies may not have been due to any topology changes around modified amino groups, but rather to the shielding action of the BLG epitope induced by the covalent attachment of BLG to the carbohydrate chains. Such a notion is supported by The reaction mixture containing DG-BLG was filtered on gel as described in the text. Fractions of 1.3 ml were collected. The absorbance of each fraction at 280 nm is indicated by a solid line, and the short dashed line shows the absorbance at 490 nm as measured by the phenol-sulfuric acid method. The numbers (1-6) in the figure show each obtained peak, and the arrow indicates the elution position of stable dimeric BLG in the BLG purification process for skimmed milk. The fractions indicated by a horizontal bar in peak 4 were pooled as DG-BLG. The inset demonstrates the SDS-PAGE patterns for DG-BLG (lane 1) and native BLG (lane 2). Electrophoresis was performed in 15% polyacrylamide gel at a constant current in 0.1% SDS and 50 mM Tris in a 38 mM glycine solution, and proteins were stained with Coomassie Brilliant Blue R250.
evidence indicating that the succinylation or guanidinylation of all amino groups in BLG did not have any effect on its affinity for anti-BLG antibodies. 21, 22) It is known that BLG has three epitopes: I, Tyr42-Ile56; II, Glu62-Thr76; and III, Ala139-Pro153. 23) Since DGONSu in DG-BLG is attached to BLG in such a manner as to shield its epitope(s) and thereby prevent anti-BLG antibodies accessing the antigens, it is suggested that the epitope(s) of BLG were not easily recognized by the anti-BLG antibodies. In addition, the lower immunogenicity induced by the shielding action of DG-ONSu also seemed to suppress the production of antibodies in vivo from the result of the reactivity with the anti-DG-BLG IgG antibodies (Table 2) .
Suppressive effect of DG-BLG on anti-BLG IgG antibody production
Further investigation of the immunological properties of DG-BLG was performed by using ELISA. In Fig. 4 , the absorption at 490 nm, which reflects the amount of anti-BLG IgG antibodies, has been plotted against the time after the initial injection of DG-BLG or PBS. The production of anti-BLG IgG antibodies was markedly increased in mice that had been immunized by the injection of BLG (Group I). Interestingly, the amount of anti-BLG IgG antibodies was decreased greatly by the injection of DG-BLG one week before immunizing with BLG (Group II). This pre-injection of DG-BLG seemed to be effective for suppressing the anti-BLG IgG antibody production in vivo. On the other hand, when the injection of DG-BLG into the mice was performed one week after immunizing with BLG, this suppression of anti-BLG IgG antibody production was greatly weakened (Group III). Tolerance against the anti-BLG IgG antibody production in vivo induced by preinjecting with DG-BLG was effectively obtained in the absence of anti-BLG IgG antibodies. These immunological phenomena indicate that pre-feeding with dairy products containing DG-BLG instead of BLG may induce tolerance against anti-BLG IgG antibody production and the hypersensitivity mediated by anti-BLG IgG antibodies in babies and infants.
Resistance of DG-BLG to proteolytic enzymes BLG was expected to show resistance to proteolytic enzymes after conjugating with DG-ONSu. The enzyme activities of trypsin, chymotrypsin, and pepsin were measured by detecting the trinitrophenylation of the amino groups which had been newly generated by the proteolysis of BLG. 17) As shown in Fig. 5A and B, the resistance of BLG to trypsin and chymotrypsin was greatly increased by modification with DG-ONSu. Trypsin predominantly cleaves peptide chains on the carboxyl side of the lysine and arginine residues, and chymotrypsin hydrolyzes peptides on the carboxyl side of the tyrosine, tryptophan, and phenylalanine residues. X-Ray crystallographic studies have suggested that many of these amino acid residues exist on the molecular surface of BLG. 20) Considering that the binding of anti-BLG IgG antibodies with BLG was prevented by DG-ONSu, it is reasonable to suggest that the introduced DG-ONSu protected the BLG molecule from the catalytic action of proteolytic enzymes and that, in the case of DG-BLG, the fragmented protein was also poorly presented to the T cell in vivo, thus suppressing the anti-BLG antibody production. Additionally, hydrolysis with trypsin was thought to have been incomplete in DG-BLG because of the decrease in positive charges induced by the covalent attachment of DG-ONSu to several amino groups of the lysine residues. Moreover, the resistance of DG-BLG to proteolysis by pepsin is shown in Fig. 5C . As there are some reports that BLG is stable at low pH values and remains mostly intact after it passes through the stomach, [24] [25] [26] BLG actually indicated high resistance to pepsin at pH 2.0. Conjugation with DG-ONSu also slightly improved the resistance of BLG to the proteolysis by pepsin.
We have demonstrated here that DG-ONSu reacted with the amino groups in BLG under mild conditions, producing the conjugate, DG-BLG, with lower immunogenicity. It was suggested that the reduced immunogenicity of DG-BLG was accomplished by inhibiting the recognition by anti-BLG IgG antibodies due to the shielding action of DG-ONSu on epitope(s) on the BLG molecular surface. The resistance of DG-BLG to proteolytic enzymes may also improve its immunological properties. Moreover, the amount of anti-BLG IgG antibodies produced in vivo was greatly suppressed by the protein tailoring method used in this study. Based on these findings, we consider that DG-ONSu can be advantageously used to prepare a protein-carbohydrate conjugate and suppress the hypersensitivity mediated by IgG antibodies in milk allergy. The results obtained from this study may also promote the development of low-allergenized milk, in which BLG is conjugated with DG-ONSu. As we succeeded in the conjugating BLG with DG-ONSu under mild conditions, the preparation of DG-BLG in milk and its subsequent purification is thought to be possible. The conjugation method for BLG reported here should be undertaken after the sterilizing stage in the milk production process or before the concentrating and drying stages in the production process for skimmed milk. The resulting low-allergenized milk and skimmed milk are useful for improving the allergy in babies and infants by the above-mentioned immunological tolerance effect. Further characterization of DG-BLG for the development of less immunogenic foods and the application of this derivative to other proteins are currently being investigated. The resistance of DG-BLG (unfilled circles) and native BLG (filled circles) to (A) trypsin, (B) chymotrypsin, and (C) pepsin was measured spectrophotometrically by using the absorption at 420 nm as described in the Materials and Methods section.
